CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine
- Fanciullino, Raphaelle
- Farnault, Laure
- Donnette, Mélanie
- Imbs, Diane-Charlotte
- Roche, Catherine
- Venton, Geoffroy
- Berda-Haddad, Yael
- Ivanov, Vadim
- Ciccolini, Joseph
- Ouafik, L’Houcine
- Lacarelle, Bruno
- Costello, Régis
Publication date
February 2018
DOI Publisher
American Society of Hematology Language
EnglishAbstract
International audienceKey Points Ara-C is the mainstay of treatment for patients with AML, and life-threatening toxicities are common. We demonstrated that cytidine deaminase downregulation predicts severe/lethal toxicities with cytarabine
Add to ORKG